Show simple item record

Factor XIa Inhibition: Is It a Novel Alternative Antithrombotic Strategy for High-Risk ACS Patients?

dc.contributor.authorGue, Ying X.
dc.contributor.authorGorog, Diana A.
dc.contributor.authorLip, Gregory Y.H.
dc.date.accessioned2024-06-18T15:00:02Z
dc.date.available2024-06-18T15:00:02Z
dc.date.issued2022-10-18
dc.identifier.citationGue , Y X , Gorog , D A & Lip , G Y H 2022 , ' Factor XIa Inhibition: Is It a Novel Alternative Antithrombotic Strategy for High-Risk ACS Patients? ' , Circulation , vol. 146 , no. 16 , pp. 1207-1209 . https://doi.org/10.1161/CIRCULATIONAHA.122.061987
dc.identifier.issn0009-7322
dc.identifier.urihttp://hdl.handle.net/2299/27979
dc.description© 2022 American Heart Association, Inc. This is the accepted manuscript version of an Editorial which has been published in final form at https://doi.org/10.1161/CIRCULATIONAHA.122.061987
dc.format.extent3
dc.format.extent179714
dc.language.isoeng
dc.relation.ispartofCirculation
dc.subjectacute coronary syndrome
dc.subjectEditorials
dc.subjectfactor XIa
dc.subjecthemorrhage
dc.subjectCardiology and Cardiovascular Medicine
dc.subjectPhysiology (medical)
dc.titleFactor XIa Inhibition: Is It a Novel Alternative Antithrombotic Strategy for High-Risk ACS Patients?en
dc.contributor.institutionDepartment of Clinical, Pharmaceutical and Biological Science
dc.contributor.institutionBasic and Clinical Science Unit
dc.contributor.institutionCentre for Health Services and Clinical Research
dc.contributor.institutionSchool of Life and Medical Sciences
dc.description.statusPeer reviewed
dc.date.embargoedUntil2023-02-27
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85140275377&partnerID=8YFLogxK
rioxxterms.versionofrecord10.1161/CIRCULATIONAHA.122.061987
rioxxterms.typeJournal Article/Review
herts.preservation.rarelyaccessedtrue


Files in this item

Thumbnail
Name:
Factor_XIa_PACIFIC_AMI_Editori ...
Size:
175.5Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record